Retrace AV Header Background Image

TESTED AGAINST BACTERIA, ENVELOPED AND NON-ENVELOPED VIRUSES

Retrace AV Product Image
UL Information Panel
buy now >

ACTIVE PROTECTION

Infectious microbes are a constant threat in our natural environment. The risk these pose increases in built environments due to the decrease in ventilation and the increased interactions between people. A surface coated with paint or varnish containing Retrace AV actively destroys a wide range of gram-positive bacteria, gram-negative bacteria, enveloped viruses, and non-enveloped viruses to significantly reduce the risk to public health.

Upon infection from any pathogen, the immune system is put under stress whilst it acts to kill the infectious organism. It is during this time, when our bodies are stressed and our immune system weakened by the primary infection, that we are vulnerable to secondary infections from other pathogens. If an individual contracts an initial bacterial infection causing pneumonia and then is infected with Coronavirus, the demand on the respiratory system would be severe and potentially life threatening.

The anti-pathogenic activity of Retrace AV reduces opportunistic primary and secondary infections in the built environment, and its effectiveness will remain active for many years (tested for 10 years) before requiring recoating. The efficacy should be verified annually by a registered service provider: contact contact@retraceav.com for details.


BATTLING THE PANDEMIC – BEYOND VACCINES

Coverage in the media is making the case for additional protection measures against the threat of COVID-19.

The Swiss Cheese Model, first created by Ian M Mackay, a virologist at the University of Queensland, Australia, highlights the need for multiple layers of defence, and Retrace AV offers one such powerful layer of defence. READ MORE >

This compelling article in The Atlantic reiterates the case, as this quote highlights: “Here, then, is the current pandemic dilemma: Vaccines remain the best way for individuals to protect themselves, but societies cannot treat vaccines as their only defense… ‘we need to take advantage of every single tool we have at our disposal.” READ MORE >


TECHNICAL DATA SHEET & SAFETY DATA

Download the Technical Data Sheet

To request a copy of the Safety Data Sheet, please email contact@retraceav.com and indicate what language you require.

ENQUIRIES

Email: contact@retraceav.com
Retrace AV Limited PO Box 100, Moreton-in-Marsh, GL56 0AN.

Sale and distribution in certain jurisdictions is restricted by regulation - click here for more information.